The PE Ratio as of May 2025 (TTM) for CSPC Pharmaceutical Group Limited (CSPCY) is 14.20

According to CSPC Pharmaceutical Group Limited’s latest financial reports and current stock price. The company's current PE Ratio is 14.20. This represents a change of 129.59% compared to the average of 6.18 of the last 4 quarters.

CSPC Pharmaceutical Group Limited (CSPCY) Historical PE Ratio (quarterly & annually)

How has CSPCY PE Ratio performed in the past?

The mean historical PE Ratio of CSPC Pharmaceutical Group Limited over the last ten years is 23.04. The current 14.20 PE Ratio has changed 6.06% with respect to the historical average. Over the past ten years (40 quarters), CSPCY's PE Ratio was at its highest in in the December 2006 quarter at 64.80. The PE Ratio was at its lowest in in the December 2024 quarter at 0.

CSPC Pharmaceutical Group Limited (CSPCY) PE Ratio by Quarter and Year

Discovering the peaks and valleys of CSPC Pharmaceutical Group Limited PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

CSPC Pharmaceutical Group Limited (CSPCY) Average PE Ratio

How has CSPCY PE Ratio performed in the past?

The current PE Ratio of CSPC Pharmaceutical Group Limited (CSPCY) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

CSPC Pharmaceutical Group Limited (CSPCY) PE Ratio vs. Peers

How is CSPCY’s PE Ratio compared to its peers?

CSPC Pharmaceutical Group Limited’s PE Ratio is less than Sanofi (17.60), greater than Organon & Co. (3.02), less than Horizon Therapeutics Public Limited Company (51.10), less than GSK plc (17.67), less than AstraZeneca PLC (26.91), less than Roche Holding AG (24.70), less than Novartis AG (16.55), greater than Merck & Co., Inc. (10.86), less than Bristol-Myers Squibb Company (17.17), less than Gilead Sciences, Inc. (20.96), less than Johnson & Johnson (16.50), less than AbbVie Inc. (76.74), less than Eli Lilly and Company (59.34),

Build a custom stock screener for CSPC Pharmaceutical Group Limited (CSPCY) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like CSPC Pharmaceutical Group Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

CSPC Pharmaceutical Group Limited (CSPCY) and other stocks custom spreadsheet templates

The easiest way to analyze a company like CSPC Pharmaceutical Group Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.